Home / Tag Archives: kidney disease

Tag Archives: kidney disease

Two Shots a Year for Hypertension? How RNA Silencing Could Transform Cardiometabolic Care

RNAi hypertension diabetes therapy concept showing an investigational injection, blood pressure monitor, liver, heart, and kidneys.

Poor medication persistence remains one of the hardest barriers to long-term blood pressure control. For people with diabetes, the stakes are especially high because hypertension adds to cardiovascular and kidney risk. Now, research into RNAi for hypertension in people with diabetes is raising an intriguing possibility: could an injection given …

Read More »

Your Eye Exam May Be Predicting More Than Vision Loss: AI Is Finding Hidden Diabetes Risks

Retinal AI analysis identifying cardiovascular, kidney, and metabolic risks in a patient with diabetes

For people with diabetes, a retinal photograph has traditionally answered one major question: Is diabetic retinopathy developing? However, artificial intelligence is beginning to uncover much more. Emerging retinal AI models for systemic risk assessment can detect patterns associated with cardiovascular disease, kidney disease, blood pressure, and metabolic health. As a …

Read More »

Could We Predict Diabetic Neuropathy Years Before Symptoms Begin?

Illustration of IgG glycosylation biomarkers, laboratory blood analysis, and peripheral nerves representing early detection of diabetic neuropathy in people with diabetes.

Early detection has always been one of the biggest challenges in diabetes care. What if doctors could identify patients at high risk for diabetic neuropathy or kidney disease years before symptoms developed? That possibility is driving exciting new research into IgG glycosylation in diabetes, an emerging area that examines subtle …

Read More »

CKM in the Wild: Applying the 2026 ADA Cardiometabolic Framework to a Real Panel

Three diverse physicians collaborating with digital icons representing heart, kidney, and glucose care, symbolizing CKM ADA 2026 integration.

What happens when a guideline finally reflects the complex realities of patient care? The ADA’s 2026 CKM standards aim to do just that—merging heart, kidney, and metabolic health into one actionable framework. But translating those recommendations into daily clinical decision-making isn’t always straightforward. This article walks through real-world composite cases …

Read More »

Inside the ADA 2026 Guidelines: A New Cardiometabolic Roadmap for Diabetes Care

Medical tools including a glucose meter, stethoscope, and ADA 2026 Guidelines clipboard, with digital icons representing cardiometabolic health

The updated ADA 2026 standards represent a major shift in how clinicians approach diabetes management. Rather than focusing solely on lowering A1C, these new recommendations promote a broader, holistic strategy that integrates cardiovascular, kidney, and metabolic (CKM) risk management into everyday care. This article breaks down the key updates and …

Read More »

When Diabetes Isn’t the Main Problem: Managing Comorbidities Without Losing Focus

Medical stethoscope, glucose meter, and a clipboard showing icons for heart, kidneys, and brain, symbolizing comorbidities in type 2 diabetes management.

Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …

Read More »